Machine learning-driven identification of exosome- related biomarkers in head and neck squamous cell carcinoma
Frontiers in Immunology · 22.05.2025 · 16
DOI: 10.3389/fimmu.2025.1590331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 22.05.2025. Verfasst von Yaodong He und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical…. Hauptthemen laut MEDLINE: Exosomes, Biomarkers, Tumor, Squamous Cell Carcinoma of Head and Neck, Machine Learning. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Head and neck squamous cell carcinoma (HNSCC) is a common cancer associated with elevated mortality rates. Exosomes, diminutive extracellular vesicles, significantly contribute to tumour development, immunological evasion, and treatment resistance. Identifying exosome-associated biomarkers in HNSCC may improve early diagnosis, treatment targeting, and patient classification.
Methods
We acquired four publically accessible HNSCC gene expression datasets from the Gene Expression Omnibus (GEO) database and mitigated batch effects utilising the ComBat technique. Differential expression analysis and exosome-related gene screening found a collection of markedly exosome-associated differentially expressed genes (ERDEGs). Subsequently, 10 key exosome-related genes were further screened by combining three machine learning methods, LASSO regression, SVM-RFE and RF, and a clinical prediction model was constructed. Furthermore, we thoroughly investigated the biological roles of these genes in HNSCC and their prospective treatment implications via functional enrichment analysis, immune microenvironment assessment, and molecular docking confirmation.
Results
The study indicated that 10 pivotal exosome-related genes identified by the machine learning method had considerable differential expression in HNSCC. Clinical prediction models developed from these genes have shown high accuracy in prognostic evaluations of HNSCC patients. Analysis of the immunological microenvironment indicated varying immune cell infiltration in HNSCC, and the association with ERDEGs proposed a potential mechanism for immune evasion. Molecular docking validation indicated novel small molecule medicines targeting these genes, establishing a theoretical foundation for pharmacological therapy in HNSCC.
Conclusion
This research identifies new exosome-related indicators for HNSCC through machine learning methodologies. The suggested biomarkers, particularly ANGPTL1, exhibit significant promise for diagnostic and prognostic uses. The investigation of the immunological microenvironment yields insights into immune modulation in HNSCC, presenting novel avenues for therapeutic targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofaci…
Zitieren
APA
He, Y., Li, Y., Tang, J., Wang, Y., Zhao, Z., Liu, R., Yang, Z., Li, H., & Wei, J. (2025). Machine learning-driven identification of exosome- related biomarkers in head and neck squamous cell carcinoma. Frontiers in Immunology, 16. https://doi.org/10.3389/fimmu.2025.1590331
Vancouver
He Y, Li Y, Tang J, Wang Y, Zhao Z, Liu R, et al. Machine learning-driven identification of exosome- related biomarkers in head and neck squamous cell carcinoma. Frontiers in Immunology. 2025;16. doi:10.3389/fimmu.2025.1590331
BibTeX
@article{He2025,
author = {He, Yaodong and Li, Yun and Tang, Jiaqi and Wang, Yan and Zhao, Zhenyan and Liu, Rong and Yang, Zihui and Li, Huan and Wei, Jianhua},
title = {Machine learning-driven identification of exosome- related biomarkers in head and neck squamous cell carcinoma},
journal = {Frontiers in Immunology},
year = {2025},
volume = {16},
doi = {10.3389/fimmu.2025.1590331}
}
EUVIMED